SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (Nasdaq: HSPT) ("HSPT"), a ...

Prof. Ciro Leonardo Pierri's expertise in structural biology, mitochondrial carrier modeling, and drug targeting—demonstrated ...

Zura Bio Ltd, which went public on March 21, 2023, is a clinical-stage biotechnology company dedicated to developing treatments for immune and inflammatory disorders. With a market capitalization of ...

Entera Bio Ltd. reported its financial results for Q1 2025, highlighting significant advancements in its development of oral peptide therapies, particularly EB613, an oral anabolic treatment for ...

N2OFF, Inc., a clean tech company focused on sustainable energy solutions, announced its definitive agreement to acquire MitoCareX Bio Ltd., a biotech firm specializing in cancer drug discovery ...

NEW YORK--(BUSINESS WIRE)--Peak Bio Co., Ltd. (“Peak Bio”), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory ...

GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions Ltd (“Bio-Thera”) announced today that it has reached a licensing agreement with Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter ...

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has ...

Karo Bio AB (publ) and Alkem Laboratories Ltd have entered into a collaboration and license agreement regarding eprotirome, currently in late-stage clinical testing for dyslipidemia. Karo Bio will ...

In a recent transaction, Zura Bio Ltd's director, Someit Sidhu, has made a significant investment in the company by acquiring shares valued at approximately $3.7 million. This purchase, conducted on ...

SL BIO Ltd. ("SL Bio" or the "Company"), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon ...